Epidemiological profile of leprosy in Brazil
DOI:
https://doi.org/10.33448/rsd-v13i4.45585Keywords:
Multibacillary leprosy; Paucibacillary leprosy; Lepromatous leprosy.Abstract
Leprosy is caused by the bacteria Mycobacterium leprae, it is an infectious disease with a prolonged latency period. Brazil is currently the second most endemic country in the world. It has great disabling potential, which is intrinsically related to stigma and prejudice about the disease. Currently, this disease persists as a public health problem in the world with strong social determination. Given this context, the objective of this study is to analyze the epidemiological profile of leprosy, at all ages, in Brazil and its regions, between 2012 and 2023. Methodology: This is an epidemiological study carried out based on data from the department of health information from the SUS (Unified Health System). The variables used were: hospital admissions, deaths, age group, color/race, sex, hospital expenses and health macro-region. Results: 49,229 hospitalizations occurred due to leprosy in the period analyzed. The biggest year for hospitalizations was 2013, the northeastern region is responsible for the highest number of hospitalizations and deaths. Interactions in the South region are more costly and the Southeast region is highlighted in the average period of leprosy patients. Men, mixed race, aged between 50 and 59 are the most affected. Conclusion: Knowing the pattern of leprosy in this population can support the planning of disease surveillance and control actions and attention to the proposed education actions must be redoubled.
References
Andrade, Y. N. L. (2016). Indicadores de qualidade das ações e serviços de saúde do programa de controle da hanseníase em capital hiperendêmica no Brasil [Dissertação de mestrado, Universidade Federal do Maranhão].
Araújo, D. A. L., Brito, K. K. G., Santana, E. M. F., Soares, V. L., & Soares, M. J. G. O. (2016). Characteristics of people of quality of life with leprosy in outpatient treatment. Revista Pesquisa em Cuidado Fundamental, 8(4), 5010-5016. http://dx.doi.org/10.9789/2175-5361.2016.v8i4.5010-5016
Basso, M. E. M., & Silva, R. L. F. (2017). Perfil clínico-epidemiológico de pacientes acometidos pela hanseníase atendidos em uma unidade de referência. Revista da Sociedade Brasileira de Clínica Médica, 15(1), 27-32. http://www.sbcm.org.br/ojs3/index.php/rsbcm/article/view/247/232
Brasil. Ministério da Saúde. (2018). Caracterização da situação epidemiológica da hanseníase e diferenças por sexo, Brasil, 2012-2016. Boletim Epidemiológico, 49(4), 1-10. https://www.saude.gov.br/images/pdf/2018/janeiro/31/2018-004-Hansen--ase-publicacao.pdf
Da Silva, P. S. R., Cunha, N. G. T., Oliveira, L. S., & Santos, M. C. A. (2020). Perfil clínico-epidemiológico de pacientes portadores de hanseníase em um município do Maranhão. Revista Eletrônica Acervo Saúde, 12(8), e3468-e3468.
Diniz, L. M., & Maciel, L. B. (2018). Leprosy: Clinical and epidemiological study in patients above 60 years in Espírito Santo state – Brazil. Anais Brasileiros de Dermatologia, 93(6), 824-828.
Freitas, L. R. S., Duarte, E. C., & Garcia, L. P. (2016). Trends of main indicators of leprosy in Brazilian municipalities with high risk of leprosy transmission, 2001-2012. BMC Infectious Diseases, 16, 472.
Goiabeira, Y. N. L., Rolim, I. L. T. P., Aquino, D. M. C. D., Soeiro, V. M. D. S., Inácio, A. S., & Queiroz, R. C. D. S. (2018). Perfil epidemiológico e clínico da hanseníase em capital hiperendêmica. Revista UFPE Online, 12(6), 1507-1513. 10.5205/1981-8963-V12I6A234693P1507-1513-2018.
Hacker, M. A., Duppre, N. C., Nery, J. A. C., Sales, A. M., & Sarno, E. N. (2012). Characteristics of leprosy diagnosed through the surveillance of contacts: A comparison with index cases in Rio de Janeiro, 1987-2010. Mem Inst Oswaldo Cruz, 107(1), 49-54.
Kaimal, S., & Sethappa, D. M. (2009). Relapse in leprosy. Indian Journal of Dermatology, Venereology, and Leprology, 75(2), 126-135.
Lockwood, D. N. J. (2019). Chronic aspects of leprosy-neglected but important. Transactions of the Royal Society of Tropical Medicine and Hygiene, 113(12), 813-817. https://doi.org/10.1093/trstmh/try131
Nobre, M. L., Illarramendi, X., Dupnik, K. M., Hacker, M. A., Nery, J. A. C., Jerônimo, S. M. B., et al. (2017). Multibacillary leprosy by population groups in Brazil: Lessons from an observational study. PLOS Neglected Tropical Diseases, 11(12), e0005364.
Nogueira, P. S. F., Marques, M. B., Coutinho, J. F. V., Maia, J. C., Silva, M. J., & Moura, E. R. F. (2017). Factors associated with the functional capacity of older adults with leprosy. Revista Brasileira de Enfermagem, 70, 711-718.
Penna, M. L., Grossi, M. A., & Penna, G. O. (2013). Perfil do país: Hanseníase no Brasil. Lepr Rev, 84(4), 308-315. https://pubmed.ncbi.nlm.nih.gov/24745130/
Rocha, M. C. N., Nobre, M. L., & Garcia, L. P. (2020). Características epidemiológicas da hanseníase nos idosos e comparação com outros grupos etários, Brasil (2016-2018). Cadernos de Saúde Pública, 36(9), e00048019.
Rodrigues, R. N., Arcêncio, R. A., & Lana, F. C. F. (2021). Epidemiologia da hanseníase e a descentralização das ações de controle no Brasil. Revista Baiana de Enfermagem, 35.
Shitsuka, D. M., Pereira, A. S., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. UFSM.
Souza, E. A. D., Heukelbach, J., Oliveira, M. L. W. D. R., Ferreira, A. F., Sena Neto, S. A. D., Raposo, M. T., & Ramos Jr, A. N. (2020). Baixo desempenho de indicadores operacionais de controle da hanseníase no estado da Bahia: Padrões espaciotemporais, 2001-2014. Revista Brasileira de Epidemiologia, 23, e200019. DOI: https://doi.org/10.1590/1980-549720200019
Souza, E. A., Ferreira, A. F., Boigny, R. N., Alencar, C. H., Heukelbach, J., Martins-Melo, F. R., et al. (2018). Hanseníase e gênero no Brasil: Tendências em área endêmica da região Nordeste 2001-2014. Revista de Saúde Pública, 52, 20. https://doi.org/10.11606/S1518-8787.2018052000335
World Health Organization. (2016). Global leprosy strategy 2016-2020: Accelerating towards a leprosy-free world [Internet]. Genebra. https://apps.who.int/iris/bitstream/handle/10665/208824/9789290225096_eng.pdf?sequence=14&isAllowed=y
World Health Organization. (2018). Global leprosy update, 2017: Reducing the disease burden due to leprosy. Weekly Epidemiological Record, 35, 445-456. https://apps.who.int/iris/bitstream/handle/10665/274290/WER9335-445-456.pdf?sequence=1&isAllowed=y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Carlos Eduardo Vieira Rollemberg; Bruno de Santana Santos; Raul Santos Silva; Rafael Joseph Macedo Paradis; Rodolfo da Silva Vieira; Keila Henrique Lisboa ; Jessica Tayná de Carvalho Vieira; Natan Martins Machado; Luiz Phillipe Silva Azevedo ; Gleide Gatto Bragança
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
